Helicobacter pylori cell wall and urease enzyme — Drug Target

All drugs that target Helicobacter pylori cell wall and urease enzyme — marketed and clinical-stage. Includes 1 drug classes acting on this target.

Drug classes

Antimicrobial combination therapy

Marketed (1)

• Modified bismuth-containing eradication treatment · Athens Medical Center · Antimicrobial combination therapy · Gastroenterology / Infectious Disease
  Bismuth-containing compounds eradicate Helicobacter pylori by disrupting bacterial cell wall integrity and inhibiting urease enzyme activity.